Australia - English - Department of Health (Therapeutic Goods Administration)

piramal critical care pty ltd - desflurane, quantity: 1 ml/ml - inhalation - excipient ingredients: - piramal desflurane is indicated as an inhalation agent for maintenance of anaesthesia. desflurane is not recommended for mask induction of anaesthesia because of a high incidence of moderate to severe upper airway adverse events.

European Union - English - EMA (European Medicines Agency)

piramal critical care b.v. - sugammadex sodium - neuromuscular blockade - sugammadex - reversal of neuromuscular blockade induced by rocuronium or vecuronium in adults.

Malta - English - Medicines Authority

piramal critical care b.v. rouboslaan 32 (ground floor), 2252 tr, voorschoten, netherlands - isoflurane - inhalation vapour, liquid - isoflurane 100 % - anesthetics

New Zealand - English - Medsafe (Medicines Safety Authority)

device technologies new zealand - sevoflurane 100%{vol} - volatile liquid for inhalation - 100% v/v - active: sevoflurane 100%{vol} - piramal sevoflurane may be used for the induction and maintenance of general anaesthesia in adult and paediatric patients undergoing surgery.

Malta - English - Medicines Authority

piramal critical care b.v. rouboslaan 32 (ground floor), 2252 tr, voorschoten, netherlands - sevoflurane - inhalation vapour, liquid - sevoflurane 100 % - anesthetics

Malta - English - Medicines Authority

piramal critical care limited - sevoflurane - inhalation vapour, liquid - sevoflurane 100 % (w/w) - anesthetics

Ireland - English - HPRA (Health Products Regulatory Authority)

piramal critical care limited - alfentanil hydrochloride - solution for injection/infusion - 500 microgram(s)/millilitre - opioid anesthetics; alfentanil

Ireland - English - HPRA (Health Products Regulatory Authority)

piramal critical care limited - fentanyl citrate - solution for injection - 50 microgram(s)/millilitre - opioid anesthetics; fentanyl

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

piramal critical care ltd - alfentanil hydrochloride - solution for injection - 5mg/1ml

European Union - English - EMA (European Medicines Agency)

piramal critical care b.v. - miglustat - gaucher disease - other alimentary tract and metabolism products, - yargesa is indicated for the oral treatment of adult patients with mild to moderate type 1 gaucher disease.yargesa may be used only in the treatment of patients for whom enzyme replacement therapy is unsuitable.yargesa is indicated for the treatment of progressive neurological manifestations in adult patients and paediatric patients with niemann-pick type c disease.